Spring 2013 Vol. 23, No. 1 Special Edition: Psychedelics in Psychology and Psychiatry

Download this entire issue or browse individual articles by title below.

Front Cover
Back Cover
Inside Front Cover 
Table of Contents 
2From the Desk of Rick Doblin, Ph.D.Rick Doblin, Ph.D.
4Stories Engage, But Data Convinces: Support for Psychedelics in PsychiatryAndrew Penn, NP
6The American Trip: Set, Setting, and Psychedelics in 20th Century PsychologyIdo Hartogsohn
10MDMA-Assisted Therapy: How Different is it from Other Psychotherapy?Michael Mithoefer, M.D.
15Update: LSD-Assisted Therapy for Anxiety Associated with Advanced- Stage Life-Threatening Diseases: A Phase-II, Double-Blind, Placebo-Controlled Dose-Response Pilot StudyPeter Gasser, M.D.
16Psychedelic Breakthroughs in Neuroscience: How Psychedelic Drugs Influenced the Growth and Development of PsychopharmacologyNicholas V. Cozzi, Ph.D.
20Serotonin, and the Past and Future of LSDDavid E. Nichols, Ph.D.
24A Clinical Report of Holotropic Breathwork in 11,000 Psychiatric Inpatients in a Community Hospital SettingJames Eyerman, M.D.
28Ketamine: A Light in the DarknessC. Alexander Paleos, M.D., Stephen Ross, M.D.
34LSD and Psilocybin for Cluster Headaches: Preventing Pain, Saving LivesRobert Wold
36A Psychotherapeutic View on the Therapeutic Effects of Ritual Ayahuasca Use in the Treatment of AddictionAnja Loizaga-Velder, Dipl. Psych.
41Teaching A Graduate Clinical Psychology Course on PsychedelicsDavid Lukoff, Ph.D.
44Love is the Answer: An Appreciation of Myron StolaroffJohn Harrison
48Review: The Psychedelic Future of the MindNese Devenot
50MAPS: Who We Are 
Inside Back Cover 
Back Cover 
Inside Front Cover
Inside Back Cover